Covid19
Conditions
Brief summary
The objective of this study will be to evaluate the effect of vaccination on breath VOC content. By capturing and analyzing the breath of anti-COVID-19 vaccinated subjects during the period of antibody production, the investigators will determine and quantify all the compounds associated with the body reaction to the COVID-19 antigen.
Detailed description
The objective of this study will be to evaluate the effect of vaccination on breath VOC content. By capturing and analyzing the breath of anti-COVID-19 vaccinated subjects during the period of antibody production, the investigators will determine and quantify all the compounds associated with the body reaction to the COVID-19 antigen. Rapidly growing serological evidence shows that IgM, IgG, and IgA antibodies against the S or N proteins evolve rapidly in the serum of asymptomatic as well as symptomatic COVID-19 patients within a week of infection or symptom onset and stay elevated with progressing disease. Since the standard serology testing at Shamir Medical center tracks the presence of IgG only, those serologic tests will be conducted before and 48 hours following the second vaccination dose. Nevertheless, since IgM antibodies are known to be produced by four to seven days following the first dose of vaccination, although IgM serology testing cannot be performed, the investigators are interested in sampling breath at this time range, in order for them to correlate it with the changes in the subjects' physiologic condition. Since this is an unknown metabolic volatile compound mixture, the goal will be to identify compounds and quantify them with a high level of precision and subsequently correlate them with the disease.
Interventions
DIAGNOSTIC_TESTvaccination against COVID19
subjects will undergo breath biopsy sampling before, 4-7 days post-first vaccination dose, and 7-10 days post-second vaccination dose.
Sponsors
Scentech Medical Technologies Ltd
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
* Age 18 to 75 years at the time of consent * Capable of understanding written and/or spoken language * Able to provide informed consent * Assigned to undergo anti-COVID-19 vaccination
Exclusion criteria
* Age under 18 years old * Under guardianship or deprived of liberty * Pregnant or lactating woman * Not eligible for anti-COVID-19 vaccination
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Association between breath VOCs and IgG in blood following second vaccination dose. | Through the study completion, up to 1 month. | VOCs profile found in breath will be correlatated with IgG profile in blood. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Association between VOCs profile and participants' clinical or demographic characteristics | Through the study completion, up to 1 month. | Identify potential exhaled biomarkers association with participants' characteristics (age, gender, symptoms-severity, etc.) |
Countries
Israel
Outcome results
None listed